Elsevier Gives Full Access to its Content on its COVID-19 Information Center for PubMed Central and Other Public Health Databases to Accelerate Fight Against Coronavirus

NEW YORK, March 13, 2020 /PRNewswire/ -- From today, Elsevier, a global leader in research publishing and information analytics specializing in science and health, is making all its research and data content on its COVID-19 Information Center available to PubMed Central, the archive of biomedical and lifescience at the US National Institutes of Health's National Library of Medicine, and the other publicly funded repositories globally, such as the WHO COVID database, for as long as needed while the public health emergency is ongoing. This additional access allows researchers to use artificial intelligence to keep up with the rapidly growing body of literature and identify trends as countries around the world address this global health crisis.

In January, Elsevier created the COVID-19 Information Center with free information in English and Mandarin on the novel coronavirus. The Information Center is updated daily with the latest research information on the virus and the disease and includes links to more than 19,500 freely available articles on ScienceDirect, Elsevier's platform of peer-reviewed scholarly literature. Since its launch, the Information Center has been visited by more than a quarter of a million scientists, researchers, clinicians and others, 15 percent of whom are in the US.

The COVID-19 Information Center is hosted on Elsevier Connect, the company's public news and information website. It is curated by Elsevier clinicians and other experts and brings together content from the company's medical journals, textbooks and clinical information solutions as well as resources from other information providers and major health and government organizations. Also available is information typically used by practicing nurses and physicians, plus resources designed specifically for patients and their families.

To improve the discoverability and utility of this important body of knowledge, Elsevier has made available all its research and data on the COVID-19 Info Center, as well copies provided to PubMed Central and other publicly funded repositories, in a machine-readable format with rights for full text and data mining, re-use and analyses for as long as needed while the public health emergency is ongoing.

About Elsevier

Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contacts
Christopher Capot
Elsevier Communications, US
[email protected]
+1-917-704-5174

Jason Chan
Elsevier Communications, APAC
[email protected]
+65-9177-8358

Andrew Davis
Elsevier Communications, EMEA
[email protected]
+44-7393-242-466

SOURCE Elsevier